Gastrointestinal stromal tumour (GIST) - sunitinib malate

The Pharmaceutical Benefits Scheme subsidises sunitinib malate for patients with a metastatic or unresectable malignant gastrointestinal stromal tumour (GIST).

For adult patients with a metastatic or unresectable malignant gastrointestinal stromal tumour, treatment with sunitinib malate (Sutent®) can be subsidised through the PBS under section 85 of the National Health Act 1953.

Restriction details

Restrictions for prescribing sunitinib malate are outlined in the Schedule of Pharmaceutical Benefits on the PBS website.

Schedule item details

Dose - Sunitinib malate is available in capsule form:

  • 12.5 mg capsules in a pack size of 28
  • 25 mg capsules in a pack size of 28
  • 37.5 mg capsule in a pack size of 28
  • 50 mg capsules in a pack size of 28

Patient eligibility

Patients must:

  • have a World Health Organisation performance status of 2 or less and have failed imatinib mesylate treatment due to resistance or intolerance, and
  • meet the relevant criteria as indicated in the restrictions and be eligible for the PBS

Sunitinib malate is not PBS-subsidised for the treatment of patients with resectable malignant gastrointestinal stromal tumour.

Lodging an application

Initial application requests must be made in writing. Send all written applications to the Complex drugs address on the contact us page.

For a patient starting initial PBS-subsidised sunitinib malate treatment for gastrointestinal stromal tumour following failure of imatinib mesylate treatment due to resistance or intolerance, you must:

Further information

For more information contact us on the Complex Drug Enquiry line.

Page last updated: 27 January 2016

This information was printed Friday 9 December 2016 from humanservices.gov.au/health-professionals/enablers/gastrointestinal-stromal-tumour-gist-sunitinib-malate It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.